![Xiang Ju Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiang Ju Gu
Directeur Technique/Scientifique/R&D chez
LAEKNA, INC.
Fortune : 939 596 $ au 31/08/2026
Profil
Xiang Ju Gu currently works at Laekna Therapeutics (Shanghai) Co., Ltd., as Director and Laekna, Inc., as Executive Director & Chief Scientific Officer from 2022.
Dr. Gu also formerly worked at China Novartis Institutes for BioMedical Research Co., Ltd., as Director-Lead Discovery from 2008 to 2019 and GP Healthcare Capital Co. , Ltd., as Venture Partner in 2019.
Dr. Gu received his doctorate degree in 1997 from The Ohio State University, graduate degree in 1988 from Chinese Academy of Sciences, and undergraduate degree in 1985 from Nankai University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LAEKNA, INC. 0,26 % | 08/09/2026 | 1 150 000 ( 0,26 % ) | 939 596 $ | 31/08/2026 |
Postes actifs de Xiang Ju Gu
| Sociétés | Poste | Début |
|---|---|---|
| LAEKNA, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Xiang Ju Gu
| Sociétés | Poste | Fin |
|---|---|---|
GP Healthcare Capital Co. , Ltd.
 GP Healthcare Capital Co. , Ltd. Part of GP Capital Co. Ltd., GP Healthcare Capital Co., Ltd. is a Chinese investment fund management company with a focus on the healthcare service industry and broader industrial and equity investments. The company is based in SH. Established in 2009, it manages large-scale funds such as the Shanghai Financial Development Investment Fund, supported by the Shanghai municipal government and major institutional investors. GP Healthcare Capital specializes in initiating, managing, and operating investment funds with a professional, market-oriented, and international approach. Its senior management team includes professionals from securities regulation, national industrial funds, and investment banks. The company operates subsidiary fund management companies across various sectors. A key branch, Shanghai GP Healthcare Capital Co., Ltd., founded in 2015, focuses on investment, mergers, and integration within the healthcare sector, managing funds and partnering with government guidance funds, asset managers, and healthcare enterprises. | Corporate Officer/Principal | 01/12/2019 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01/04/2019 |
Formation de Xiang Ju Gu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
 Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GP Healthcare Capital Co. , Ltd.
GP Healthcare Capital Co. , Ltd. Part of GP Capital Co. Ltd., GP Healthcare Capital Co., Ltd. is a Chinese investment fund management company with a focus on the healthcare service industry and broader industrial and equity investments. The company is based in SH. Established in 2009, it manages large-scale funds such as the Shanghai Financial Development Investment Fund, supported by the Shanghai municipal government and major institutional investors. GP Healthcare Capital specializes in initiating, managing, and operating investment funds with a professional, market-oriented, and international approach. Its senior management team includes professionals from securities regulation, national industrial funds, and investment banks. The company operates subsidiary fund management companies across various sectors. A key branch, Shanghai GP Healthcare Capital Co., Ltd., founded in 2015, focuses on investment, mergers, and integration within the healthcare sector, managing funds and partnering with government guidance funds, asset managers, and healthcare enterprises. | |
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. | |
Laekna, Inc.
 Laekna, Inc. BiotechnologyHealth Technology Operates as an clinical-stage global biotechnology company | Health Technology |
